Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kees Fluiter

Showing results (11-20 of 36) with videos related to

Pageof 4
Sort By:
Plos One|October 3, 2012
MicroRNA-146a: a key regulator of astrocyte-mediated inflammatory responseAnand Iyer, Emanuele Zurolo, Avanita Prabowo, et al.
Chembiochem : a European Journal of Chemical Biology|April 30, 2005
On the in vitro and in vivo properties of four locked nucleic acid nucleotides incorporated into an anti-H-Ras antisense oligonucleotideKees Fluiter, Miriam Frieden, Jeroen Vreijling, et al.
Human Molecular Genetics|January 29, 2011
Impairment of the tRNA-splicing endonuclease subunit 54 (tsen54) gene causes neurological abnormalities and larval death in zebrafish models of pontocerebellar hypoplasiaPaul R Kasher, Yasmin Namavar, Paula van Tijn, et al.
Acta Neuropathologica|March 17, 2015
M. leprae components induce nerve damage by complement activation: identification of lipoarabinomannan as the dominant complement activatorNawal Bahia El Idrissi, Pranab K Das, Kees Fluiter, et al.
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|October 12, 2022
Tackling Neuroinflammation After Traumatic Brain Injury: Complement Inhibition as a Therapy for Secondary InjuryInge A M van Erp, Iliana Michailidou, Thomas A van Essen, et al.
Current Research in Neurobiology|March 17, 2023
The systemic inhibition of the terminal complement system reduces neuroinflammation but does not improve motor function in mouse models of CMT1A with overexpressed <i>PMP22</i>Iliana Michailidou, Jeroen Vreijling, Matthijs Rumpf, et al.
Journal of Gastroenterology|August 20, 2013
Toll-like receptor 4 activation in Barrett's esophagus results in a strong increase in COX-2 expressionRomy E Verbeek, Peter D Siersema, Fiebo J Ten Kate, et al.
American Journal of Respiratory and Critical Care Medicine|March 16, 2013
Glucocorticoid-induced changes in gene expression of airway smooth muscle in patients with asthmaChing Yong Yick, Aeilko H Zwinderman, Peter W Kunst, et al.
Nucleic Acids Research|February 1, 2003
In vivo tumor growth inhibition and biodistribution studies of locked nucleic acid (LNA) antisense oligonucleotidesKees Fluiter, Anneloor L M A ten Asbroek, Marit B de Wissel, et al.
Frontiers in Cellular Neuroscience|July 17, 2023
Ldlr-/-.Leiden mice develop neurodegeneration, age-dependent astrogliosis and obesity-induced changes in microglia immunophenotype which are partly reversed by complement component 5 neutralizing antibodyFlorine Seidel, Kees Fluiter, Robert Kleemann, et al.
Pageof 4

Showing results (11-20 of 36) with videos related to

Sort By:
Pageof 4
Plos One|October 3, 2012
MicroRNA-146a: a key regulator of astrocyte-mediated inflammatory responseAnand Iyer, Emanuele Zurolo, Avanita Prabowo, et al.
Chembiochem : a European Journal of Chemical Biology|April 30, 2005
On the in vitro and in vivo properties of four locked nucleic acid nucleotides incorporated into an anti-H-Ras antisense oligonucleotideKees Fluiter, Miriam Frieden, Jeroen Vreijling, et al.
Human Molecular Genetics|January 29, 2011
Impairment of the tRNA-splicing endonuclease subunit 54 (tsen54) gene causes neurological abnormalities and larval death in zebrafish models of pontocerebellar hypoplasiaPaul R Kasher, Yasmin Namavar, Paula van Tijn, et al.
Acta Neuropathologica|March 17, 2015
M. leprae components induce nerve damage by complement activation: identification of lipoarabinomannan as the dominant complement activatorNawal Bahia El Idrissi, Pranab K Das, Kees Fluiter, et al.
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|October 12, 2022
Tackling Neuroinflammation After Traumatic Brain Injury: Complement Inhibition as a Therapy for Secondary InjuryInge A M van Erp, Iliana Michailidou, Thomas A van Essen, et al.
Current Research in Neurobiology|March 17, 2023
The systemic inhibition of the terminal complement system reduces neuroinflammation but does not improve motor function in mouse models of CMT1A with overexpressed <i>PMP22</i>Iliana Michailidou, Jeroen Vreijling, Matthijs Rumpf, et al.
Journal of Gastroenterology|August 20, 2013
Toll-like receptor 4 activation in Barrett's esophagus results in a strong increase in COX-2 expressionRomy E Verbeek, Peter D Siersema, Fiebo J Ten Kate, et al.
American Journal of Respiratory and Critical Care Medicine|March 16, 2013
Glucocorticoid-induced changes in gene expression of airway smooth muscle in patients with asthmaChing Yong Yick, Aeilko H Zwinderman, Peter W Kunst, et al.
Nucleic Acids Research|February 1, 2003
In vivo tumor growth inhibition and biodistribution studies of locked nucleic acid (LNA) antisense oligonucleotidesKees Fluiter, Anneloor L M A ten Asbroek, Marit B de Wissel, et al.
Frontiers in Cellular Neuroscience|July 17, 2023
Ldlr-/-.Leiden mice develop neurodegeneration, age-dependent astrogliosis and obesity-induced changes in microglia immunophenotype which are partly reversed by complement component 5 neutralizing antibodyFlorine Seidel, Kees Fluiter, Robert Kleemann, et al.
Pageof 4